EU could approve Pfizer, Moderna vaccines in December – Bloomberg

Dhwani Mehta FXStreet

“Pfizer & BioNtech and Moderna Inc. could receive conditional European Union (EU) marketing authorization for their Covid-19 vaccines in the second half of next month,” Bloomberg reported, citing comments from the European Commission President Ursula von der Leyen.

Key quotes

“The European Medicines Agency is in daily contact with the US Food and Drug Administration about the evaluation of the vaccines in order to “synchronize” assessment.”

“If all proceeds with no problems, EMA tells us that the conditional marketing authorization for BioNTech and Moderna could happen as early as the second half of December 2020.”

“The Brussels-based commission will “hopefully soon” reach a vaccine-supply agreement with Moderna and is also in talks with Novavax Inc.”

Meanwhile, the EU is reportedly said to pay more than EUR9 billion for Pfizer and CureVac vaccines, Reuters reported, citing an EU official involved in the talks.

Additional details

To pay EUR15.50 per dose of Pfizer coronavirus vaccine candidate.

To pay EUR10 per dose of CureVac coronavirus vaccine candidate.

Related reads

Author

Dhwani Mehta

FXStreet

Residing in Mumbai (India), Dhwani is a Senior Analyst and Manager of the Asian session at FXStreet. She has over 10 years of experience in analyzing and covering the global financial markets, with specialization in Forex and commodities markets.

EUR/USD flirts with daily highs, retargets 1.1900

EUR/USD regains upside traction, returning to the 1.1880 zone and refocusing its attention to the key 1.1900 barrier. The pair’s slight gains comes against the backdrop of a humble decline in the US Dollar as investors continue to assess the latest US CPI readings and the potential Fed’s rate path.

GBP/USD remains well bid around 1.3650

GBP/USD maintains its upside momentum in place, hovering around daily highs near 1.3650 and setting aside part of the recent three-day drop. Cable’s improved sentiment comes on the back of the Greenback’s irresolute price action, while recent hawkish comments from the BoE’s Pill also collaborate with the uptick.

Gold clings to gains just above $5,000/oz

Gold is reclaiming part of the ground lost on Wednesday’s marked decline, as bargain-hunters keep piling up and lifting prices past the key $5,000 per troy ounce. The precious metal’s move higher is also underpinned by the slight pullback in the US Dollar and declining US Treasury yields across the curve.

Crypto Today: Bitcoin, Ethereum, XRP in choppy price action, weighed down by falling institutional interest

Bitcoin's upside remains largely constrained amid weak technicals and declining institutional interest. Ethereum trades sideways above $1,900 support with the upside capped below $2,000 amid ETF outflows.

Week ahead – Data blitz, Fed Minutes and RBNZ decision in the spotlight

US GDP and PCE inflation are main highlights, plus the Fed minutes. UK and Japan have busy calendars too with focus on CPI. Flash PMIs for February will also be doing the rounds. RBNZ meets, is unlikely to follow RBA’s hawkish path.

Ripple Price Forecast: XRP potential bottom could be in sight

Ripple edges up above the intraday low of $1.35 at the time of writing on Friday amid mixed price actions across the crypto market. The remittance token failed to hold support at $1.40 the previous day, reflecting risk-off sentiment amid a decline in retail and institutional sentiment.